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Value of the data {#sec0001a}
=================

•Datasets in this work will benefit researchers in predicting molecular properties from the molecular structures without the need to perform experiments that are costly and time-consuming.•Datasets in this article will help in applying computational power to be combined chemically and biologically in order to streamline from optimization, development, design, and drug discovery.•The additional value of the data results of QSAR and also the interactions between functional groups in the molecules of greatest activity can be understood.•Using *in silico* screening tools, predictions of drug responses can significantly contribute to preclinical researches which are purely computational. The tools that can help biologists to prioritize and strategize their researches for candidate compounds, which are of great benefit for resourceful experimental planning and costs reduction.•The improvement of accurate and computational efficiency are two important reasons for the continuous interest in the development of new, efficient, reliable, numerical stability, and modularly designed methods in the quantum theory of the atomic nuclei and the electrons.

1. Data description {#sec0001}
===================

[Table 1](#tbl0001){ref-type="table"} presents the schematic structure and names of investigated 1, 2, 3-triazole-pyrimidine hybrids, showing the twenty (20) minimized and optimized compounds. These were further employed in performing quantum calculations for the molecular descriptors, QSAR modeling, and docking simulations. The compound consists of 20 derivatives ([Table 1](#tbl0001){ref-type="table"}) taken from Ma et al. [@bib0001].Table 1Schematic structure and names of 1, 2, 3-triazole-pyrimidine hybrids.Table 1![](fx2.gif)

Tables SI 1 and 2 (in the supporting information) present the datasets of the selected molecular parameters obtained by B3LYP/6--31G\*\* using DFT [@bib0002]. The molecular descriptors extracted were based on the electronic properties of the investigated compounds. The descriptors include HOMO, LUMO, HOMO-LUMO, chemical hardness, band gaps, solvation energy, chemical potential, area volumes, diploe moments, softness, global nucleophilicity, ovality, log P, polar surface areas, polarizability, hydrogen bond donors, hydrogen bond acceptors, an average of Mulliken charges on all heteroatoms and number of organic atom.

[Table 2](#tbl0002){ref-type="table"} presents the 20 compounds with their corresponding fitting datasets for the predicted IC~50~ and the experimental IC~50~ for EC-109, showing that the predicted IC~50~ fitted well into the observed IC~50~ and this explicitly revealed that the developed QSAR model replicated the experimental bioactivity of the compound under consideration.Table 2Predicted and experimental IC~50~ for EC-109 of the compound **L1- L20**.Table 2![](fx3.gif)![](fx4.gif)![](fx5.gif)![](fx6.gif)

[Fig. 1](#fig0001){ref-type="fig"} presents the correlation between predicted and observed IC~50~ for EC-109, which shows that the QSAR model developed linked the activities of the compounds to their biological activities, and that the calculated IC~50~ fitted well into the observed IC~50~. Moreover, statistical analyses are carried out, the correlation coefficient (R^2^), gave 0.999 indicating a very good fit; as well as the effectiveness of the developed QSAR model to predict the anti-Esophageal cancer activity of triazole-pyrimidine compounds as shown in Eq. (1) generated for EC-109 inserted in [Table 3](#tbl0003){ref-type="table"}. The calculated cross-validation (CV.R^2^) was 0.999 which shows its reliability and acceptability because the value obtained is greater than 0.5 \[[@bib0003],[@bib0004]\]. Also, the predicting power of the QSAR model developed was believed to be enhanced, since adjusted correlation coefficient ($\mspace{6mu} R_{a}^{2}$) was calculated to be 0.995 which is greater than 0.6 [@bib0002] as presented in [Table 3](#tbl0003){ref-type="table"}.Fig. 1The correlation between observed and predicted IC~50~ for EC-109.Fig 1Table 3The QSAR model equation for EC-109.Table 3Eq. (1)*NP*R^2^CV. R^2^$R_{a}^{2}$5240.36 + 21.4466(HOMO) - 593.467(LUMO) + 0.680013(SE) + 1.34285(MW) - 3289.86(OVALITY) −298.047(Log P) + 18.1521(DM) −38.8328(PSA) + 9.33277(AREA) + 1410.97(HBD) + 107.061(HBA) −50.0707 (HET) + 2133.54 (N1) −2395.80 (N2)+ 2891.43 (N4) −1797.75 (N5) −2397.38 (N6) + 4966.48 (N7)20180.9990.9990.995

[Fig. 2](#fig0002){ref-type="fig"} shows the treatment of raw receptor and removal of water molecules and other residues apart from the target compounds using the Discovery studio. [Fig. 3](#fig0003){ref-type="fig"} presents the transparent views of docked complexes showing ligand-receptor interactions in the binding pocket for the best selected active compounds (**L1, L4, L6, L11, L15, L16, L17, L18, L19**, and **L20**) against EC-109 (receptor) using Pymol which was based on the lowest IC~50~ in the range of ≤ 10 μM \[[@bib0001],[@bib0005],[@bib0006]\]. While the other non-selected compounds have moderate to fair activity as presented in [Fig. 4](#fig0004){ref-type="fig"}. Besides, [Figs. 3](#fig0003){ref-type="fig"} and [4](#fig0004){ref-type="fig"} reflect the analysis of the docked complex which shows the ligand conformation in the active gouge of the receptor (EC-109).Fig. 2Treatment of raw receptor.Fig 2Fig. 3Transparent view of docked complexes showing ligand-receptor interactions in the binding pocket for the best selected active compounds **(L1, L4, L6, L11, L15, L16, L17, L18, L19** and **L20**) against EC-109 using Pymol.Fig 3Fig. 4Transparent view of docked complexes showing ligand-receptor interactions in the binding pocket for the non-selected compounds with moderate to fair activity against EC-109 using Pymol.Fig 4

[Table 4](#tbl0004){ref-type="table"} presents the datasets obtained from docking studies of the 20 compounds with their respective interactions among drug residues and EC-109; suggesting the conformation of the ligands in the active gouge of the receptor and free binding energy. [Table 4](#tbl0004){ref-type="table"} also reveals the dataset of compound **L4**as the best ligand with minimum IC~50~ and the corresponding energy interaction of free binding energy. Besides, the datasets of some compounds observed to form the number of hydrogen bonds in the gouge of the receptor are also shown in [Table 4](#tbl0004){ref-type="table"}. The datasets of the compounds **L5**and **L18**that formed one hydrogen bond each are also listed in [Table 4](#tbl0004){ref-type="table"}. For **L5**the hydrogen bond datasets include (SER-26, LIG: N) and (GLU-108, LIG: O) with the bond distance of 2.2 and 3.3 respectively, while L8 formed four hydrogen bonds (PHE-14, LIG: O; ILE-103, LIG: N; ASP-104, LIG: N; SER-106, LIG: H) with bond distance 2.9, 3.6, 3.4, 2.1 respectively ([Table 4](#tbl0004){ref-type="table"}). The datasets of compounds **L1-L4, L6-L7, L9-L19,** and **L20**presented in [Table 4](#tbl0004){ref-type="table"} were with neither hydrogen bonding nor any bond distance. Although, there are still many other non-bonding interactions (π-π, cationic-π, anionic-π) that can occur in ligand-receptor interactions in which hydrogen bonding is just one of the interactions that predominate with EC-109.Table 4Interactions among residues of drugs and EC-109.Table 4MolBinding Energy (kcal/mol)IC~50~ (µM)H-bond between amino acid and drugDistance of H-bond between amino acid and drug (Å)**L1**−8.07.96----**L2**−8.531.98----**L3**−8.228.45----**L4**−8.01.42----**L5**−6.824.39SER-26, LIG: N2.2**L6**−7.99.67----**L7**−8.115.57----**L8**−8.464(i) PHE-14, LIG: O (ii) ILE-103, LIG:N (iii) ASP-104, LIG: N (iv) SER-106, LIG: H2.9, 3.6, 3.4, 2.1**L9**−8.123.04----**L10**−6.725.76----**L11**−7.99.74----**L12**−6.055.73----**L13**−6.711.22----**L14**−6.164----**L15**−6.55.08----**L16**−7.03.58----**L17**−6.44.65----**L18**−6.65.85GLU-108, LIG: O3.3**L19**−6.97.54----**L20**−7.33.09----**5-Fu**−5.110.81

[Fig. 5](#fig0005){ref-type="fig"} presents the correlation and relation between the IC~50~ and binding energy of the compounds**L1, L4, L6, L11, L15-L20** against EC-109 due to their higher binding free energy than **5-Fu**. They follow the sequence **L4 **\> **L20 **\> **L16 **\> **L17 **\>** L15 **\> **L18 **\> **L19 **\> **L1 **\> **L6 **\> **L11 **\> **5-Fu** in the order of increased IC~50~ and decreased binding energy.Fig. 5Relationship between the IC~50~ and binding energy of **L1, L4, L6, L11, L15, L16, L17, L18, L19** and **L20**compounds against EC-109.Fig 5

2. Materials, methods and experimental design {#sec0002}
=============================================

2.1. Materials {#sec0003}
--------------

The materials used in this work were Spartan'14 software for geometry analysis and optimization of the ligand in calculating quantum chemical process, QSAR model was obtained by Gretl software, docking study was carried out through different software such as Discovery studio 4.1 (used for the initial preparation of both receptor visualization and ligand exploration), autodock tool 1.5.6 (used to set grid box on the binding site around the compound) and autodock vina 1.1.2 (for binding energy evaluation and docking) while pymol 1.7.4.4 was used for molecular visualizations.

2.2. Minimization and optimization {#sec0004}
----------------------------------

The used of quantum calculations for molecular descriptor were performed using the hybrids of 1, 2, 3-triazole-pyrimidine which comprises 20 derivatives obtained from the previous work [@bib0001]. Optimization was performed on the compounds using DFT with the standard 6--31G\*\* (d, p) basis set. Three parameters including the Becke gradient exchange correction [@bib0007], the Lee, Yang, and Parr correlation functionals (i.e. B3LYP) [@bib0008]. Molecular descriptors generated from the molecules investigated and were used to develop QSAR model in describing the bioactivity and binding affinities upon the docking of the molecules with the receptors

2.3. Molecular descriptors {#sec0005}
--------------------------

The molecular descriptor is usually extracted from the electronic property of the compounds under investigation. Descriptors used in the present work includes the HOMO, LUMO, HOMO-LUMO, chemical hardness, band gaps, solvation energy, chemical potential, area volumes, diploe moments, softness, global nucleophilicity, ovality, log P, polarizability, and polar surface area. The chemical hardness, *η*, for an *N*-electron system with total energy *E* and *η* was expressed as:$$\eta = \mspace{6mu}\left( \frac{\delta^{2}E}{\delta N^{2}} \right)_{v{(r)}} \approx \frac{1}{2}\left( {IE - EA} \right) \approx \frac{1}{2}\left( {E_{LUMO} - E_{HOMO}} \right)$$

Where IE is the vertical ionization energy approximated as -*E*~HOMO~ and EA for the vertical electron affinity as -*E*~LUMO~ [@bib0009]. The global softness is defined as the inverse of chemical hardness$\left( {S = \frac{1}{\eta}} \right)$. The electron affinity can also be used in combination with IE to give electronic chemical potential *μ,* negative of electron affinity (-χ) defined by Zhou et al. \[[@bib0010],[@bib0011]\], as the characteristic of electronegativity of molecules:$$\chi = - \mu = \left( \frac{\delta E}{\delta N} \right)_{v{(r)}} \approx \frac{1}{2}\left( {IE + EA} \right) \approx - \frac{1}{2}\left( {E_{HOMO} + E_{LUMO}} \right)$$

The global electrophilicity index *ω* introduced by Parr et al. [@bib0011], was calculated using the relation between the electronic chemical potential *μ* and chemical hardness *η*:$$\omega = \mspace{6mu}\frac{\mu^{2}}{2\eta}$$

According to the definition, the index measures the tendency of a species to accept an electron. It has been reported that high electrophilicity and nucleophilicity of a heterocycle corresponds to the extreme opposite scales of the global reactivity index \[[@bib0012],[@bib0013]\]. Good electrophiles can be considered when the values of *μ* and ω are high, whereas, good and better reactive nucleophiles are obtained when the values of *μ* and ω are lower.

2.4. Validation of QSAR model {#sec0006}
-----------------------------

The QSAR model generated in this work was validated using statistical equations. Cross-validation (R^2^) and Adjusted R^2^ were considered suitable. Cross-validation governs the reliability of the QSAR model to be used for specific sets of data. In addition, it was employed as an analytical tool for estimating the prognostic/predictive controls of the equation.$$\text{CV}.R^{2} = 1 - \frac{\sum\left( {Y\,\text{obs} - Y\,\text{cal}} \right)^{2}}{\sum\left( {Y\,\text{obs} - \overline{Y}\,\text{obs}} \right)^{2}\mspace{6mu}}$$$$R_{a}^{2} = \mspace{6mu}\frac{\left( {N - 1} \right) \times R^{2\mspace{6mu}} - P}{N - 1 - P}$$

The model is regarded as prognostic, if $R_{Pred}^{2} > 0.6$. However, R^2^ is the coefficient of multiple determinations for multiple regressions. R^2^ measures the closeness of the data to the fitting of the regression line. The better fit of R^2^ value is judged by its closeness to unity (i.e. 1)

2.5. Molecular docking and binding energy evaluation {#sec0007}
----------------------------------------------------

Molecular docking interaction typically brings about the formation of stable protein-protein or protein-ligand complexes which is essential for carrying out the biological functions. Therefore, it helps to predict the receptor-ligand complex conformation. It explains the relations of *y*- variable to two or more *x*-variables (or the transformation of *x*-variables). Thus, Gretl software was employed in this work to generate an equation which is given as:$$Y = \mspace{6mu}\alpha + \mspace{6mu}\beta X + \mspace{6mu}\varepsilon$$

Where *X* is the regressor (also known as the predictor or independent variable), *Y* is the response (also known as the dependent variable), the parameters; *α* and *β* describe the relations of *X* with *Y* and the term ε signifies the error model (the error is also called the residual) [@bib0014]. Thus, R^2^ is considered to determine the efficiency and linearity of the analysis.

### 2.5.1. Discovery studio {#sec0008}

This is software used for the simulation of the molecules and used to prepare (to remove water molecules and another residue(s) apart from the target compounds) the ligands and the receptors before subjecting them to docking studies with the autodock tool software as shown in [Fig. 2](#fig0002){ref-type="fig"}.

### 2.5.2. Autodock {#sec0009}

Autodock tool was designed for simulation of how small molecules including the substrates or drug candidates bind to the receptors of known 3-D structure. It further helps in locating the active binding sites (gorges) in the receptors. Based on these important features, we used Autodock Vina, a new generation of docking software from the molecular graphic laboratory. To achieve the desired goal, the required commands are as follows: vina --config conf.txt --log log.txt to do the calculations and vinasplit --input out.pdbqt to split the result in order of the scoring. Lastly, Pymol, which is a post-docking software was employed for viewing the conformation and hydrophobic interaction of the ligand and the receptor (EC-109).
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